Publication | Closed Access

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

OncologyMedicinePathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentPharmacologyRadiation OncologyLung Cancer